Cell Counting Market

7500+ companies worldwide approach us every year for their revenue growth initiatives

Global top 2000 strategist rely on us for their growth strategies.

80% of fortune 2000 companies rely on our research to identify new revenue sources.

30000 High Growth Opportunities

95% renewal rate

KNOW MORE

Cell Counting Market by Product (Instruments (Spectrophotometer, Hemocytometer, Flow Cytometer, Hematology Analyzers), Consumables (Reagent, Microplate)), Cancer, Stem Cell Research, End User (Pharmaceutical, Hospital, Research) & Region - Global Forecast to 2025

FREE BROCHURE FREE SAMPLE REPORT

Report Code: BT 3379 Jun, 2020, by marketsandmarkets.com

The global cell counting market in terms of revenue was estimated to be worth $10.4 billion in 2020 and is poised to reach $14.5 billion by 2025, growing at a CAGR of 6.7% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The market growth is largely driven by factors such as growing funding for cell-based research, rising incidence of chronic and infectious diseases, growing biotechnology and biopharmaceutical industries, the development of enhanced solutions and improved image analysis, and the growing use of high-throughput flow cytometry and automated hematology analyzers. On the other hand, the high cost of cell analysis is expected to hinder market growth to a certain extent.

Cell Counting Market - Attractive Opportunities

The medical application segment of cell counting industry is expected to grow at the highest CAGR during the forecast period

On the basis of application, the cell counting market is segmented into research, medical, and industrial applications. The medical application segment will grow at the highest CAGR in the global market. Increasing government initiatives in stem cell research and the wide usage of cell counting in research are the major factors driving the growth of the research applications segment during the forecast period.

The hospitals and diagnostic laboratories segment of cell counting industry is expected to grow at the highest CAGR during the forecast period

On the basis of end users, the cell counting market is segmented into research institutes, hospitals & diagnostic laboratories, pharmaceutical & biotechnology companies and CROs, and other end users. The hospitals and diagnostic laboratories will grow at the highest CAGR during the forecast period. The high growth of this segment can primarily be attributed to the growing regulatory approvals for cell culture-based vaccines, increasing pharmaceutical R&D expenditure, and commercial expansion of various pharmaceutical companies.

Cell Counting Market - By Region

The Asia Pacific region is expected to account for the largest share of the cell counting industry during the forecast period

The APAC region of the cell counting industry is expected to grow at the highest CAGR during the forecast period. The large growth of this segment can be attributed to factors such as the growing number of proteomics, genomics, and stem cell research activities; increasing research funding; increasing investments by pharmaceutical and biotechnology companies; and the growing trend of research infrastructure modernization.

The major companies in the cell counting market include Danaher Corporation (US), Thermo Fisher Scientific Inc. (US), Becton, Dickinson and Company (US), Merck KGaA (Germany), and Bio-Rad Laboratories (US)

Danaher (US) is a global leader in the global cell counting market. The company operates in more than 60 countries and has a broad product portfolio in instruments and consumables in the cell counting segment. The product portfolio includes mass spectroscopy, microplate readers, assay kits, flow cytometry, and reagents. Danaher has undertaken several acquisitions to continue developing cell counting products in this market. The company has acquired Beckmann Coulter, Molecular Devices, SCIEX, Leica Microsystems, and Integrated DNA Technologies. In the same year, Danaher also acquired the Biopharma business of GE Life Sciences, GE Healthcare, further strengthening its presence in the global market.

Scope of the Cell Counting Industry

Report Metric	Details
Market Revenue in 2020	$10.4 billion
Projected Revenue by 2025	$14.5 billion
Revenue Rate	Poised to Grow at a CAGR of 6.7%
Market Driver	Funding for cell based research
Market Opportunity	Growth in stem cell research

The study categorizes the cell counting market to forecast revenue and analyze trends in each of the following submarkets:

By Product

Consumables and Accessories
- Media, Sera, and Reagents
- Assay Kits
- Microplates
- Accessories
- Other Consumables
Instruments
- Spectrophotometers
  - Single-mode Readers
  - Multi-mode Readers
- Flow Cytometers
- Hematology Analyzers
  - Fully Automated Analyzers
  - Semi-automated Analyzers
- Cell Counters
  - Automated Cell Counters
  - Hemocytometers/manual Cell Counters
- Microscopes

By Application

Research Applications
- Cancer Research
- Immunology Research
- Neurology Research
- Stem Cell Research
- Other Research Applications
Clinical & Diagnostic Applications
Industrial Applications

By End Users

Research Institutes
Hospitals & Diagnostic Laboratories
Pharmaceutical & Biotechnology Companies and Contract Research Organizations (CROs)
Other End Users

By Region

North America
- US
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- ROE
Asia Pacific
- China
- Japan
- India
- ROAPAC
Latin America
The Middle East and Africa

Recent Developments of Cell Counting Industry:

In 2020, Danaher (US) acquired the Biopharma business of GE Life Sciences, GE Healthcare. This business will be established as a standalone operating company with Danaher’s Life Science segment.
In 2019, Agilent Technologies acquired BioTek Instruments, Inc. (US). This acquisition will strengthen Agilent Technologies' position in the cell counting market.
In 2019, Perkin Elmer entered into an agreement with Accenture to join Accenture’s Open Partner Ecosystem Program to help researchers accelerate drug discovery and improve patient outcomes.

Frequently Asked Questions (FAQ):

What is the projected market revenue value of the global cell counting market?

The global cell counting market boasts a total revenue value of $14.5 billion by 2025.

What is the estimated growth rate (CAGR) of the global cell counting market?

The global cell counting market has an estimated compound annual growth rate (CAGR) of 6.7% and a revenue size in the region of $10.4 billion in 2020.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 24)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
    1.3 MARKET SCOPE
           1.3.1 MARKETS COVERED
           1.3.2 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY
    1.5 LIMITATIONS
    1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY (Page No. - 27)
    2.1 RESEARCH DATA
           2.1.1 SECONDARY DATA
           2.1.2 PRIMARY DATA
           2.1.3 DATA TRIANGULATION
    2.2 MARKET ESTIMATION METHODOLOGY
    2.3 MARKET GROWTH RATE PROJECTIONS
    2.4 RESEARCH ASSUMPTIONS

3 EXECUTIVE SUMMARY (Page No. - 33)

4 PREMIUM INSIGHTS (Page No. - 37)
    4.1 CELL COUNTING MARKET OVERVIEW
    4.2 NORTH AMERICA: MARKET SHARE, BY PRODUCT & COUNTRY (2019)
    4.3 GLOBAL MARKET SHARE, BY END USER (2019)
    4.4 GLOBAL CELL COUNTING INDUSTRY SHARE, BY APPLICATION (2019)

5 MARKET OVERVIEW (Page No. - 40)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
           5.2.1 DRIVERS
                    5.2.1.1 Funding for cell-based research
                    5.2.1.2 Rising incidence of chronic and infectious diseases
                    5.2.1.3 Growing biotechnology and biopharmaceutical industries
                    5.2.1.4 Development of enhanced solutions and improved image analysis
                    5.2.1.5 Growing use of high-throughput flow cytometry and automated hematology analyzers
           5.2.2 RESTRAINTS
                    5.2.2.1 High cost of cell analysis instruments
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Applications of cell counting in personalized medicine
                    5.2.3.2 Growth in stem cell research
           5.2.4 CHALLENGES
                    5.2.4.1 Dearth of skilled professionals in clinical laboratories

6 INDUSTRY INSIGHTS (Page No. - 47)
    6.1 INTRODUCTION
           6.1.1 INDUSTRY TRENDS
                    6.1.1.1 Growing focus on the stem cell research industry
                    6.1.1.2 Recombinant DNA technology
                    6.1.1.3 Integration of advanced technologies
    6.2 VALUE CHAIN ANALYSIS
           6.2.1 RESEARCH
           6.2.2 MANUFACTURING
           6.2.3 MARKETING & SALES
    6.3 REGULATORY CHALLENGES
           6.3.1 STRINGENT FDA REQUIREMENTS
           6.3.2 ANALYTE-SPECIFIC REAGENT RULE (ASR) 1997
           6.3.3 VALIDATION PROTOCOLS FOR CELL-BASED ASSAYS
           6.3.4 LACK OF GUIDELINES FOR LABORATORY-DEVELOPED TESTS (LDTS) FOR FLUORESCENCE ASSAYS

7 CELL COUNTING MARKET, BY PRODUCT (Page No. - 51)
    7.1 INTRODUCTION
    7.2 CONSUMABLES
           7.2.1 MEDIA, SERA, AND REAGENTS
                    7.2.1.1 Increasing focus on research to drive the demand for cell counting media, sera, and reagents
           7.2.2 ASSAY KITS
                    7.2.2.1 Assay kits offer convenience over standalone reagents—a key factor driving market growth
           7.2.3 MICROPLATES
                    7.2.3.1 Use of microplates in drug discovery research will increase the demand for microplates
           7.2.4 ACCESSORIES
                    7.2.4.1 Increase in use of cell counting instruments will fuel the demand for related accessories
           7.2.5 OTHER CONSUMABLES
    7.3 INSTRUMENTS
           7.3.1 SPECTROPHOTOMETERS
                    7.3.1.1 Single-mode readers
                               7.3.1.1.1 Compactness and affordability of single-mode spectrophotometers to drive the growth of this market
                    7.3.1.2 Multi-mode readers
                               7.3.1.2.1 Multi-mode spectrophotometers have high accuracy, reliability, and flexibility
           7.3.2 FLOW CYTOMETERS
                    7.3.2.1 Ability of flow cytometer to assess multi-parametric cellular parameters along with cell counting is driving adoption
           7.3.3 HEMATOLOGY ANALYZERS
                    7.3.3.1 Fully automated analyzers
                               7.3.3.1.1 High yield and benefits over semi-automated hematology analyzers to drive adoption of automated hematology analyzers
                    7.3.3.2 Semi-automated hematology analyzers
                               7.3.3.2.1 Affordability of semi-automated analyzers to drive the market growth among small labs and hospitals
           7.3.4 CELL COUNTERS
                    7.3.4.1 Automated cell counters
                               7.3.4.1.1 Reliable and quick results are supporting the growth of this market
                    7.3.4.2 Hemocytometers/manual cell counters
                               7.3.4.2.1 Manual cell counters are rapidly being replaced by automated cell counters due to their low accuracy
           7.3.5 MICROSCOPES
                    7.3.5.1 Microscopes play a key role in cell analysis

8 CELL COUNTING MARKET, BY APPLICATION (Page No. - 85)
    8.1 INTRODUCTION
    8.2 RESEARCH APPLICATIONS
           8.2.1 CANCER RESEARCH
                    8.2.1.1 Rising incidence of cancer to support the growth of this segment
           8.2.2 IMMUNOLOGY RESEARCH
                    8.2.2.1 High incidence of infectious diseases and increased demand for advanced vaccines to propel market growth
           8.2.3 NEUROLOGY RESEARCH
                    8.2.3.1 Increasing incidence of neurological disorders to propel market growth
           8.2.4 STEM CELL RESEARCH
                    8.2.4.1 Rising investments in stem cell research to drive the growth of this application segment
           8.2.5 OTHER RESEARCH APPLICATIONS
    8.3 MEDICAL APPLICATIONS
           8.3.1 NONINVASIVE PRENATAL DIAGNOSIS
                    8.3.1.1 Rising prevalence of genetic diseases to drive market growth
           8.3.2 IN VITRO FERTILIZATION
                    8.3.2.1 Increasing demand for IVF procedures to support the growth of this application segment
           8.3.3 CIRCULATING TUMOR CELL DETECTION
                    8.3.3.1 Rising prevalence of cancer contributes to the growth of this segment
    8.4 INDUSTRIAL APPLICATIONS
           8.4.1 CELL COUNTING HAS SIGNIFICANT IMPORTANCE IN THE FOOD, DAIRY, ENVIRONMENT, AND MICROBIAL INDUSTRIES

9 CELL COUNTING MARKET, BY END USER (Page No. - 107)
    9.1 INTRODUCTION
    9.2 RESEARCH INSTITUTES
           9.2.1 GROWING PREVALENCE OF INFECTIOUS DISEASES AND CANCER TO DRIVE THE MARKET FOR THIS END-USER SEGMENT
    9.3 HOSPITALS & DIAGNOSTIC LABORATORIES
           9.3.1 DEVELOPMENT OF COMPLEX AND HIGHLY SPECIALIZED TESTS & ASSAYS TO SUPPORT MARKET GROWTH
    9.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND CONTRACT RESEARCH ORGANIZATIONS (CROS)
           9.4.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND CROS ARE THE FASTEST-GROWING END USERS OF THE GLOBAL MARKET
    9.5 OTHER END USERS

10 CELL COUNTING MARKET, BY REGION (Page No. - 119)
     10.1 INTRODUCTION
     10.2 NORTH AMERICA
             10.2.1 US
                       10.2.1.1 The US held the largest share of North America in 2019
             10.2.2 CANADA
                       10.2.2.1 Availability of research funding for regenerative medicine and clinical research activities drives the market growth
     10.3 EUROPE
             10.3.1 GERMANY
                       10.3.1.1 Germany to command the largest share of the European market
             10.3.2 FRANCE
                       10.3.2.1 Increasing investments in life science R&D to support market growth
             10.3.3 UK
                       10.3.3.1 Increasing initiatives to strengthen the academic research infrastructure to drive market growth
             10.3.4 ITALY
                       10.3.4.1 Favorable funding scenario and increasing research activities to support market growth
             10.3.5 SPAIN
                       10.3.5.1 Increasing funding for cell-based research and international scientific collaborations to drive market growth
             10.3.6 REST OF EUROPE
     10.4 ASIA PACIFIC
             10.4.1 JAPAN
                       10.4.1.1 Japan dominated the Asia Pacific market in 2019
             10.4.2 CHINA
                       10.4.2.1 China to register the highest CAGR in the APAC market during the forecast period
             10.4.3 INDIA
                       10.4.3.1 The increasing use of flow cytometry in HIV research to drive market growth
             10.4.4 REST OF ASIA PACIFIC
     10.5 LATIN AMERICA
     10.6 MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE (Page No. - 191)
     11.1 INTRODUCTION
     11.2 MARKET RANKING ANALYSIS, 2019
     11.3 COMPETITIVE LEADERSHIP MAPPING
             11.3.1 VISIONARY LEADERS
             11.3.2 DYNAMIC DIFFERENTIATORS
             11.3.3 INNOVATORS
             11.3.4 EMERGING COMPANIES
     11.4 COMPETITIVE SCENARIO
             11.4.1 KEY PRODUCT & SERVICE LAUNCHES
             11.4.2 KEY ACQUISITIONS
             11.4.3 KEY PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS

12 COMPANY PROFILES (Page No. - 196)
(Business overview, Products offered, Recent Developments, SWOT analysis, MNM view)*
     12.1 DANAHER CORPORATION
     12.2 THERMO FISHER SCIENTIFIC
     12.3 BECTON, DICKINSON AND COMPANY
     12.4 MERCK KGAA
     12.5 BIO-RAD LABORATORIES INC.
     12.6 ABBOTT LABORATORIES
     12.7 PERKINELMER, INC.
     12.8 AGILENT TECHNOLOGIES, INC.
     12.9 CORNING
     12.10 TECAN
     12.11 BOULE DIAGNOSTICS AB
     12.12 OLYMPUS CORPORATION
     12.13 HORIBA
     12.14 SYSMEX CORPORATION
     12.15 SIEMENS HEALTHINEERS AG
     12.16 F. HOFFMANN-LA ROCHE AG
     12.17 LUMINEX CORPORATION
     12.18 NEXCELOM BIOSCIENCE LLC
     12.19 TIP BIOSYSTEMS
     12.20 LOGOS BIOSYSTEMS, INC.

*Details on Business overview, Products offered, Recent Developments, SWOT analysis, MNM view might not be captured in case of unlisted companies.

13 APPENDIX (Page No. - 241)
     13.1 DISCUSSION GUIDE
     13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     13.3 AVAILABLE CUSTOMIZATIONS
     13.4 RELATED REPORTS
     13.5 AUTHOR DETAILS

LIST OF TABLES (265 Tables)

TABLE 1 GLOBAL CANCER INCIDENCE, 2018 VS. 2025
TABLE 2 COST OF FLOW CYTOMETERS
TABLE 3 CELL COUNTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 4 CELL COUNTING CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 5 CELL COUNTING CONSUMABLES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 6 NORTH AMERICA: CELL COUNTING CONSUMABLES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 7 EUROPE: CELL COUNTING CONSUMABLES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 8 APAC: CELL COUNTING CONSUMABLES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 9 CELL COUNTING MEDIA, SERA, AND REAGENTS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 10 NORTH AMERICA: CELL COUNTING MEDIA, SERA, AND REAGENTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 11 EUROPE: CELL COUNTING MEDIA, SERA, AND REAGENTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 12 APAC: CELL COUNTING MEDIA, SERA, AND REAGENTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 13 CELL COUNTING ASSAY KITS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 14 NORTH AMERICA: CELL COUNTING ASSAY KITS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 15 EUROPE: CELL COUNTING ASSAY KITS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 16 APAC: CELL COUNTING ASSAY KITS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 17 CELL COUNTING MICROPLATES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 18 NORTH AMERICA: CELL COUNTING MICROPLATES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 19 EUROPE: CELL COUNTING MICROPLATES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 20 APAC: CELL COUNTING MICROPLATES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 21 CELL COUNTING ACCESSORIES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 22 NORTH AMERICA: CELL COUNTING ACCESSORIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 23 EUROPE: CELL COUNTING ACCESSORIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 24 APAC: CELL COUNTING ACCESSORIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 25 OTHER CELL COUNTING CONSUMABLES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 26 NORTH AMERICA: OTHER CELL COUNTING CONSUMABLES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 27 EUROPE: OTHER CELL COUNTING CONSUMABLES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 28 APAC: OTHER CELL COUNTING CONSUMABLES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 29 CELL COUNTING INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 30 CELL COUNTING INSTRUMENTS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 31 NORTH AMERICA: CELL COUNTING INSTRUMENTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 32 EUROPE: CELL COUNTING INSTRUMENTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 33 APAC: CELL COUNTING INSTRUMENTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 34 CELL COUNTING SPECTROPHOTOMETERS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 35 NORTH AMERICA: CELL COUNTING SPECTROPHOTOMETERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 36 EUROPE: CELL COUNTING SPECTROPHOTOMETERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 37 APAC: CELL COUNTING SPECTROPHOTOMETERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 38 CELL COUNTING SINGLE-MODE READERS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 39 CELL COUNTING MULTI-MODE READERS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 40 CELL COUNTING FLOW CYTOMETERS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 41 CELL COUNTING FLOW CYTOMETRY VOLUME MARKET, BY REGION, 2018–2025 (UNITS)
TABLE 42 NORTH AMERICA: CELL COUNTING FLOW CYTOMETERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 43 EUROPE: CELL COUNTING FLOW CYTOMETERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 44 APAC: CELL COUNTING FLOW CYTOMETERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 45 CELL COUNTING HEMATOLOGY ANALYZERS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 46 NORTH AMERICA: CELL COUNTING HEMATOLOGY ANALYZERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 47 EUROPE: CELL COUNTING HEMATOLOGY ANALYZERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 48 APAC: CELL COUNTING HEMATOLOGY ANALYZERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 49 FULLY AUTOMATED CELL COUNTING HEMATOLOGY ANALYZERS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 50 SEMI-AUTOMATED CELL COUNTING HEMATOLOGY ANALYZERS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 51 CELL COUNTERS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 52 NORTH AMERICA: CELL COUNTERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 53 EUROPE: CELL COUNTERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 54 APAC: CELL COUNTERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 55 AUTOMATED CELL COUNTERS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 56 HEMATOCYTOMETERS/MANUAL CELL COUNTERS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 57 CELL COUNTING MICROSCOPES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 58 CELL COUNTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 59 GLOBAL MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 60 GLOBAL MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2018–2025 (USD MILLION)
TABLE 61 NORTH AMERICA: MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 62 EUROPE: MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 63 APAC: MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 64 GLOBAL MARKET FOR CANCER RESEARCH, BY REGION, 2018–2025 (USD MILLION)
TABLE 65 NORTH AMERICA: MARKET FOR CANCER RESEARCH, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 66 EUROPE: MARKET FOR CANCER RESEARCH, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 67 APAC: MARKET FOR CANCER RESEARCH, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 68 GLOBAL CELL COUNTING INDUSTRY FOR IMMUNOLOGY RESEARCH, BY REGION, 2018–2025 (USD MILLION)
TABLE 69 NORTH AMERICA: MARKET FOR IMMUNOLOGY RESEARCH, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 70 EUROPE: MARKET FOR IMMUNOLOGY RESEARCH, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 71 APAC: MARKET FOR IMMUNOLOGY RESEARCH, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 72 GLOBAL MARKET FOR NEUROLOGY RESEARCH, BY REGION, 2018–2025 (USD MILLION)
TABLE 73 NORTH AMERICA: MARKET FOR NEUROLOGY RESEARCH, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 74 EUROPE: MARKET FOR NEUROLOGY RESEARCH, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 75 APAC: MARKET FOR NEUROLOGY RESEARCH, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 76 GLOBAL MARKET FOR STEM CELL RESEARCH, BY REGION, 2018–2025 (USD MILLION)
TABLE 77 NORTH AMERICA: MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 78 EUROPE: MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 79 APAC: MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 80 CELL COUNTING MARKET FOR OTHER RESEARCH APPLICATIONS, BY REGION, 2018–2025 (USD MILLION)
TABLE 81 NORTH AMERICA: MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 82 EUROPE: MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 83 APAC: MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 84 GLOBAL CELL COUNTING INDUSTRY FOR MEDICAL APPLICATIONS, BY REGION, 2018–2025 (USD MILLION)
TABLE 85 NORTH AMERICA: MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 86 EUROPE: MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 87 APAC: MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 88 GLOBAL MARKET FOR INDUSTRIAL APPLICATIONS, BY REGION, 2018–2025 (USD MILLION)
TABLE 89 NORTH AMERICA: MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 90 EUROPE: MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 91 APAC: MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 92 MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 93 GLOBAL CELL COUNTING INDUSTRY FOR RESEARCH INSTITUTES, BY REGION, 2018–2025 (USD MILLION)
TABLE 94 NORTH AMERICA: MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 95 EUROPE: MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 96 APAC: MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 97 CELL COUNTING MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2018–2025 (USD MILLION)
TABLE 98 NORTH AMERICA: MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 99 EUROPE: MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 100 APAC: MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 101 GLOBAL CELL COUNTING INDUSTRY FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018–2025 (USD MILLION)
TABLE 102 NORTH AMERICA: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 103 EUROPE: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 104 APAC: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 105 GLOBAL MARKET FOR OTHER END USERS, BY REGION, 2018–2025 (USD MILLION)
TABLE 106 NORTH AMERICA: MARKET FOR OTHER END USERS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 107 EUROPE: MARKET FOR OTHER END USERS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 108 APAC: MARKET FOR OTHER END USERS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 109 GLOBAL MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 110 NORTH AMERICA: CELL COUNTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 111 NORTH AMERICA: MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 112 NORTH AMERICA: CELL COUNTING INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 113 NORTH AMERICA: SPECTROPHOTOMETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 114 NORTH AMERICA: HEMATOLOGY ANALYZERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 115 NORTH AMERICA: CELL COUNTERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 116 NORTH AMERICA: CELL COUNTING CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 117 NORTH AMERICA: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 118 NORTH AMERICA: MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 119 NORTH AMERICA: CELL COUNTING INDUSTRY, BY RESEARCH APPLICATIONS , 2018–2025 (USD MILLION)
TABLE 120 US: CELL COUNTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 121 US: CELL COUNTING INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 122 US: SPECTROPHOTOMETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 123 US: HEMATOLOGY ANALYZERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 124 US: CELL COUNTERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 125 US: CELL COUNTING CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 126 US: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 127 US: MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 128 US: CELL COUNTING INDUSTRY, BY RESEARCH APPLICATIONS , 2018–2025 (USD MILLION)
TABLE 129 CANADA: CELL COUNTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 130 CANADA: CELL COUNTING INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 131 CANADA: SPECTROPHOTOMETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 132 CANADA: HEMATOLOGY ANALYZERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 133 CANADA: CELL COUNTERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 134 CANADA: CELL COUNTING CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 135 CANADA: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 136 CANADA: MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 137 CANADA: MARKET, BY RESEARCH APPLICATIONS , 2018–2025 (USD MILLION)
TABLE 138 EUROPE: CELL COUNTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 139 EUROPE: MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 140 EUROPE: CELL COUNTING INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 141 EUROPE: SPECTROPHOTOMETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 142 EUROPE: HEMATOLOGY ANALYZERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 143 EUROPE: CELL COUNTERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 144 EUROPE: CELL COUNTING CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 145 EUROPE: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 146 EUROPE: MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 147 EUROPE: CELL COUNTING INDUSTRY, BY RESEARCH APPLICATIONS, 2018–2025 (USD MILLION)
TABLE 148 GERMANY: CELL COUNTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 149 GERMANY: CELL COUNTING INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 150 GERMANY: SPECTROPHOTOMETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 151 GERMANY: HEMATOLOGY ANALYZERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 152 GERMANY: CELL COUNTERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 153 GERMANY: CELL COUNTING CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 154 GERMANY: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 155 GERMANY: MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 156 GERMANY: CELL COUNTING INDUSTRY, BY RESEARCH APPLICATIONS , 2018–2025 (USD MILLION)
TABLE 157 FRANCE: CELL COUNTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 158 FRANCE: CELL COUNTING INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 159 FRANCE: SPECTROPHOTOMETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 160 FRANCE: HEMATOLOGY ANALYZERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 161 FRANCE: CELL COUNTERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 162 FRANCE: CELL COUNTING CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 163 FRANCE: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 164 FRANCE: MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 165 FRANCE: MARKET, BY RESEARCH APPLICATIONS , 2018–2025 (USD MILLION)
TABLE 166 UK: CELL COUNTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 167 UK: CELL COUNTING INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 168 UK: SPECTROPHOTOMETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 169 UK: HEMATOLOGY ANALYZERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 170 UK: CELL COUNTERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 171 UK: CELL COUNTING CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 172 UK: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 173 UK: MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 174 UK: CELL COUNTING INDUSTRY, BY RESEARCH APPLICATIONS , 2018–2025 (USD MILLION)
TABLE 175 ITALY: CELL COUNTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 176 ITALY: CELL COUNTING INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 177 ITALY: SPECTROPHOTOMETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 178 ITALY: HEMATOLOGY ANALYZERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 179 ITALY: CELL COUNTERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 180 ITALY: CELL COUNTING CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 181 ITALY: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 182 ITALY: MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 183 ITALY: CELL COUNTING INDUSTRY, BY RESEARCH APPLICATIONS , 2018–2025 (USD MILLION)
TABLE 184 SPAIN: CELL COUNTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 185 SPAIN: CELL COUNTING INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 186 SPAIN: SPECTROPHOTOMETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 187 SPAIN: HEMATOLOGY ANALYZERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 188 SPAIN: CELL COUNTERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 189 SPAIN: CELL COUNTING CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 190 SPAIN: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 191 SPAIN: MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 192 SPAIN: MARKET, BY RESEARCH APPLICATIONS , 2018–2025 (USD MILLION)
TABLE 193 ROE: CELL COUNTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 194 ROE: CELL COUNTING INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 195 ROE: SPECTROPHOTOMETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 196 ROE: HEMATOLOGY ANALYZERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 197 ROE: CELL COUNTERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 198 ROE: CELL COUNTING CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 199 ROE: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 200 ROE: MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 201 ROE: CELL COUNTING INDUSTRY, BY RESEARCH APPLICATIONS , 2018–2025 (USD MILLION)
TABLE 202 ASIA PACIFIC: CELL COUNTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 203 ASIA PACIFIC: MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 204 ASIA PACIFIC: CELL COUNTING INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 205 ASIA PACIFIC: SPECTROPHOTOMETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 206 ASIA PACIFIC: HEMATOLOGY ANALYZERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 207 ASIA PACIFIC: CELL COUNTERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 208 ASIA PACIFIC: CELL COUNTING CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 209 ASIA PACIFIC: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 210 ASIA PACIFIC: MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 211 ASIA PACIFIC: CELL COUNTING INDUSTRY, BY RESEARCH APPLICATIONS , 2018–2025 (USD MILLION)
TABLE 212 JAPAN: CELL COUNTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 213 JAPAN: CELL COUNTING INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 214 JAPAN: SPECTROPHOTOMETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 215 JAPAN: HEMATOLOGY ANALYZERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 216 JAPAN: CELL COUNTERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 217 JAPAN: CELL COUNTING CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 218 JAPAN: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 219 JAPAN: MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 220 JAPAN: MARKET, BY RESEARCH APPLICATIONS , 2018–2025 (USD MILLION)
TABLE 221 CHINA: CELL COUNTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 222 CHINA: CELL COUNTING INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 223 CHINA: SPECTROPHOTOMETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 224 CHINA: HEMATOLOGY ANALYZERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 225 CHINA: CELL COUNTERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 226 CHINA: CELL COUNTING CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 227 CHINA: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 228 CHINA: MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 229 CHINA: CELL COUNTING INDUSTRY, BY RESEARCH APPLICATIONS , 2018–2025 (USD MILLION)
TABLE 230 INDIA: CELL COUNTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 231 INDIA: CELL COUNTING INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 232 INDIA: SPECTROPHOTOMETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 233 INDIA: HEMATOLOGY ANALYZERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 234 INDIA: CELL COUNTERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 235 INDIA: CELL COUNTING CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 236 INDIA: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 237 INDIA: MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 238 INDIA: CELL COUNTING INDUSTRY, BY RESEARCH APPLICATIONS , 2018–2025 (USD MILLION)
TABLE 239 ROAPAC: CELL COUNTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 240 ROAPAC: CELL COUNTING INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 241 ROAPAC: SPECTROPHOTOMETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 242 ROAPAC: HEMATOLOGY ANALYZERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 243 ROAPAC: CELL COUNTERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 244 ROAPAC: CELL COUNTING CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 245 ROAPAC: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 246 ROAPAC: MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 247 ROAPAC: MARKET, BY RESEARCH APPLICATIONS , 2018–2025 (USD MILLION)
TABLE 248 LATIN AMERICA: CELL COUNTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 249 LATIN AMERICA: CELL COUNTING INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 250 LATIN AMERICA: SPECTROPHOTOMETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 251 LATIN AMERICA: HEMATOLOGY ANALYZERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 252 LATIN AMERICA: CELL COUNTERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 253 LATIN AMERICA: CELL COUNTING CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 254 LATIN AMERICA: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 255 LATIN AMERICA: MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 256 LATIN AMERICA: CELL COUNTING INDUSTRY, BY RESEARCH APPLICATIONS , 2018–2025 (USD MILLION)
TABLE 257 MIDDLE EAST & AFRICA: CELL COUNTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 258 MIDDLE EAST & AFRICA: CELL COUNTING INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 259 MIDDLE EAST & AFRICA: SPECTROPHOTOMETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 260 MIDDLE EAST & AFRICA: HEMATOLOGY ANALYZERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 261 MIDDLE EAST & AFRICA: CELL COUNTERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 262 MIDDLE EAST & AFRICA: CELL COUNTING CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 263 MIDDLE EAST & AFRICA: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 264 MIDDLE EAST & AFRICA: MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 265 MIDDLE EAST & AFRICA: CELL COUNTING INDUSTRY, BY RESEARCH APPLICATIONS , 2018–2025 (USD MILLION)

LIST OF FIGURES (40 Figures)

FIGURE 1 BREAKDOWN OF PRIMARIES: CELL COUNTING MARKET
FIGURE 2 DATA TRIANGULATION METHODOLOGY
FIGURE 3 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE-BASED ESTIMATION), 2019
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 2 (MNM REPOSITORY ANALYSIS-BASED ESTIMATION), 2019
FIGURE 5 GLOBAL MARKET SIZE ESTIMATION, 2019
FIGURE 6 GLOBAL CELL COUNTING INDUSTRY: CAGR PROJECTIONS
FIGURE 7 GLOBAL MARKET SHARE, BY PRODUCT, 2019
FIGURE 8 GLOBAL MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
FIGURE 9 GLOBAL MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
FIGURE 10 GEOGRAPHICAL SNAPSHOT OF THE GLOBAL MARKET
FIGURE 11 GROWING FUNDING FOR CELL-BASED RESEARCH TO DRIVE MARKET GROWTH
FIGURE 12 CONSUMABLES TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICAN MARKET IN 2019
FIGURE 13 RESEARCH INSTITUTES DOMINATED THE GLOBAL MARKET IN 2019
FIGURE 14 RESEARCH APPLICATIONS ACCOUNTED FOR THE LARGEST SHARE OF THE GLOBAL MARKET IN 2019
FIGURE 15 GLOBAL MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 16 PHARMACEUTICAL & BIOPHARMACEUTICAL R&D EXPENDITURE, 2017–2024
FIGURE 17 VALUE CHAIN ANALYSIS OF GLOBAL CELL COUNTING INDUSTRY: RESEARCH AND MANUFACTURING PHASE CONTRIBUTES MAXIMUM VALUE
FIGURE 18 GEOGRAPHIC SNAPSHOT CELL COUNT MARKET: ASIA-PACIFIC TO REGISTER THE HIGHEST MARKET GROWTH DURING THE FORECAST PERIOD
FIGURE 19 NORTH AMERICA: MARKET SNAPSHOT
FIGURE 20 EUROPE: MARKET SNAPSHOT
FIGURE 21 ASIA PACIFIC: MARKET SNAPSHOT
FIGURE 22 RANK OF COMPANIES IN THE GLOBAL MARKET, 2019
FIGURE 23 CELL COUNTING MARKET (GLOBAL) COMPETITIVE LEADERSHIP MAPPING, 2019
FIGURE 24 DANAHER CORPORATION: COMPANY SNAPSHOT (2019)
FIGURE 25 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2019)
FIGURE 26 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2019)
FIGURE 27 MERCK KGAA: COMPANY SNAPSHOT (2019)
FIGURE 28 BIO-RAD LABORATORIES INC: COMPANY SNAPSHOT (2019)
FIGURE 29 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2019)
FIGURE 30 PERKINELMER, INC.: COMPANY SNAPSHOT (2019)
FIGURE 31 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2019)
FIGURE 32 CORNING: COMPANY SNAPSHOT (2019)
FIGURE 33 TECAN: COMPANY SNAPSHOT (2019)
FIGURE 34 BOULE DIAGNOSTICS AB: COMPANY SNAPSHOT (2019)
FIGURE 35 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2019)
FIGURE 36 HORIBA: COMPANY SNAPSHOT (2019)
FIGURE 37 SYSMEX CORPORATION: COMPANY SNAPSHOT (2019)
FIGURE 38 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2019)
FIGURE 39 F. HOFFMANN-LA ROCHE AG: COMPANY SNAPSHOT (2019)
FIGURE 40 LUMINEX CORPORATION: COMPANY SNAPSHOT (2019)

The study involved two major activities in estimating the current size of the cell counting market. Exhaustive research was conducted to collect information on the market as well as its peer and parent markets. The next step was to validate these findings, assumptions, and sizing estimates with industry experts across the value chain through primary research. Revenue-based estimation approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the size of the segments and subsegments.

Secondary Research

In the secondary research process, various sources such as Hoovers, Bloomberg BusinessWeek, Forbes, and Dun & Bradstreet were referred to identify and collect information useful for this technical, market-oriented, and commercial study of the cell counting market. These secondary sources include government sources such as World Health Organization (WHO), National Institutes of Health (NIH), National Center for Biotechnology Information (NCBI), United States Food and Drug Administration (USFDA), International Society for Laboratory Hematology (ISLH), American Institute for Cancer Research (AICR), American Society of Hematology (ASH), Canadian Hematology Society (CHS), Canadian Association of Nurses in Oncology (CANO), Centers for Disease Control and Prevention (CDC), European Society of Clinical Cell Analysis (ESCCA), American Society of Hematology (ASH), European Hematology Association (EHA), European Commission (EC), German Society for Cytometry (DGfZ), International Clinical Cytometry Society (ICCS), International Society for Advancement of Cytometry (ISAC), Organisation for Economic Co-operation and Development (OECD), Society for Laboratory Automation and Screening (SLAS), Cytometry Society, Center for Drug Evaluation and Research (CDER), European Federation of Pharmaceutical Industries and Associations (EFPIA), BioPharm Magazine, Expert Interviews, and MarketsandMarkets Analysis. Secondary sources also include corporate & regulatory filings (such as annual reports, SEC filings, investor presentations, and financial statements); business magazines & research journals; press releases; and trade, business, and professional associations, among others.

Primary Research

The cell counting market comprises several stakeholders such as research institutes, cell counting solution providers, pharmaceutical and biotechnology companies, Contract Research Organizations (CROs), government associations and healthcare associations/institutes, cell counting services and software providing companies, and market research and consulting firms. Several primary interviews were conducted with market experts from both the demand side (such as personnel from managers in healthcare provider organizations) and the supply side (such as C-level and D-level executives, product managers, marketing & sales managers of key manufacturers, distributors, and channel partners, among others) across four major regions - North America, Europe, Asia Pacific, and the Rest of the World. Approximately 80% and 20% of primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

Cell Counting Market - Primary Participants

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

For calculating the global market value, segmental revenues were arrived at based on the revenue mapping of major players active in the cell counting market. This process involved the following steps:

Generating a list of the major global players operating in the cell counting market.
Mapping the annual revenues generated by major global players from the cell counting market (or the nearest reported business unit/product, service category)
Estimating the revenue from the related market and extrapolating to the global number as of 2019.
Calculating 100% of the global market value of cell counting market based on bottom-up and company revenue approach and year on year CAGR projections.

Data Triangulation

After arriving at the overall market size—using the market size estimation processes explained above—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides of the cell counting market.

Report Objectives

To define, describe, and forecast the global cell counting market, by product, application, end user, and region.
To provide detailed information regarding the major factors influencing the growth of the global cell counting market (drivers, restraints, opportunities, and challenges)
To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall global cell counting market
To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
To forecast the size (by value) of the market segments with respect to five main regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
To profile key players and comprehensively analyze their core competencies in terms of key market developments and growth strategies
To track and analyze competitive developments such as product launches, acquisitions, collaborations, expansions, and partnerships in the cell counting market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report: